KNIGHT THERAPEUTICS INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.73 CAD | +0.70% |
|
+0.17% | +10.40% |
| 03-22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
| 03-21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
Quotes 5-day view
Delayed Quote Toronto S.E.| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|
| Last | 5.82 $ | 5.72 $ | 5.69 $ | 5.73 $ |
| Volume | 26 122 | 22 021 | 59 340 | 41 264 |
| Change | +0.52% | -1.72% | -0.52% | +0.70% |
| Opening | 5.79 | 5.87 | 5.70 | 5.81 |
| High | 5.88 | 5.87 | 5.72 | 5.84 |
| Low | 5.78 | 5.72 | 5.56 | 5.68 |
Performance
| 1 day | +0.70% | ||
| 1 week | +0.17% | ||
| Current month | +8.11% | ||
| 1 month | +8.11% | ||
| 3 months | +2.32% | ||
| 6 months | +27.62% | ||
| Current year | +10.40% | ||
| 1 year | +27.33% | ||
| 3 years | +5.14% | ||
| 5 years | -20.75% | ||
| 10 years | -6.68% |
Volumes
marketsDaily volume
41 264
Estimated daily volume
41 264
Avg. Volume 20 sessions
60 440
Daily volume ratio
0.68
Avg. Volume 20 sessions CAD
346 321.20
Avg. Volume 20 sessions USD
253 368.59
Record volume 1
9 500 549
Record volume 2
3 952 800
Record volume 3
3 938 231
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CAD)
578 927 004
Capitalization (USD)
423 542 996
Net sales (CAD)
328 199 000
Net sales (USD)
240 110 388
Number of employees
725
Sales / Employee (CAD)
452 688
Sales / Employee (USD)
331 187
Free-Float
53.56 %
Free-Float capitalization (CAD)
310 062 846
Free-Float capitalization (USD)
226 841 978
Average Daily Capital Traded
0.06%
Highs and lows
1 week
5.56
5.88
1 month
5.235.95
Current year
5.135.95
1 year
4.355.95
3 years
4.286.20
5 years
4.288.88
10 years
4.2811.03
Indicators
Moving average 5 days
5.75
Moving average 20 days
5.62
Moving average 50 days
5.50
Moving average 100 days
5.46
Price spread / (MMA5)
+0.35%
Price spread / (MMA20)
-1.94%
Price spread / (MMA50)
-4.00%
Price spread / (MMA100)
-4.74%
STIM
RSI 9 days
51.29
RSI 14 days
53.97
Sector Comparison - Specialty & Advanced Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.70% | +0.17% | +10.40% | +27.33% | 424M | ||
| -1.30% | +1.05% | +3.57% | -6.37% | 70.44B | ||
| +0.23% | +0.80% | +10.97% | -12.91% | 8.94B | ||
| +0.24% | +0.97% | -16.83% | +21.01% | 4.75B | ||
| +4.34% | +23.11% | +43.48% | +109.09% | 4.5B | ||
| -0.70% | +2.45% | +3.20% | +29.43% | 3.85B | ||
| +1.60% | -5.78% | +19.75% | -6.95% | 2.38B | ||
| +3.66% | +12.49% | -21.36% | -40.50% | 2.34B | ||
| +0.05% | -4.81% | -29.67% | -45.78% | 2.2B | ||
| -0.66% | +1.14% | +8.38% | -21.00% | 1.96B | ||
| -.--% | -.--% | - | - | 1.64B | ||
| +0.82% | +7.56% | +1.14% | -12.25% | 1.25B | ||
| +1.41% | +4.82% | +16.02% | +30.46% | 1.01B | ||
| +1.54% | +16.53% | -24.30% | -27.93% | 981M | ||
| +1.82% | +4.19% | -37.08% | -49.99% | 880M | ||
| 0.00% | +7.66% | +31.02% | +42.45% | 838M | ||
| Average | +0.86% | +3.25% | +1.25% | +2.41% | ||
| Weighted average by Cap. | -0.50% | +3.64% | +3.91% | -1.15% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +10.40% | ||
| 2023 | +0.19% | ||
| 2022 | -2.26% | ||
| 2021 | -0.93% | ||
| 2020 | -29.42% | ||
| 2019 | -1.43% | ||
| 2018 | -7.46% | ||
| 2017 | -22.63% | ||
| 2016 | +39.12% | ||
| 2015 | +11.56% | ||
| 2014 | +80.68% |
- Stock Market
- Equities
- GUD Stock
- Quotes Knight Therapeutics Inc.
